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INTRODUCTION 
Myopia is the commonest refractive error worldwide. It causes 
visual impairment to children and adults. Prevalence of high myopia 
varies with age and ethnicity. High myopia has found to be visually 
debilitating and affects day to day activities of the individual. There are 
several treatment options available for correcting high myopia. One of the 
recent modality of treatment is with Phakic Intraocular Lens. Phakic IOL 
means that natural crystalline lens is retained and an intraocular lens 
(IOL) is placed into the eye. The phakic IOL implant functions as an 
internal contact lens and the view through the phakic IOL is natural and 
of a good quality. Phakic IOLs are used to treat high myopia or 
hypermetropia with or without astigmatism who are not fit for LASIK or 
with mild keratoconus. Treatment of high myopia with posterior chamber 
phakic intra-ocular lens has been found to be an effective way of 
correcting high myopia. In our study we are going to analyze the efficacy 
and visual outcome of posterior chamber phakic IOLs in patients of high 
myopia. 
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REFRACTION 
There are three major refracting surfaces to be considered in eye. 
They are the anterior corneal surface and the two surfaces of the lens. The 
effect of the posterior corneal surface is very small compared to other 
three as the difference in refractive index between cornea and aqueous is 
not large. 
Refractive indices of the transparent media of the eye (as described 
by Gullstrand). 
 Air 1.000 
 Cornea 1.376 
 Aqueous humour 1.336 
 Lens (cortex-core) 1.386–1.406 
 Vitreous humour 1.336 
Position of refracting surfaces of eye (in mm behind anterior surface 
of cornea) (as described by Gullstrand). 
 Anterior surface of cornea 0 
 Posterior surface of cornea 0.5 
 Anterior surface of the lens 3.6 
 Posterior surface of the lens 7.2 
 Anterior surface of lens core 4.15 
 Posterior surface of lens core 6.56  
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Radii of curvature of refracting surfaces of eye (in mm) (as described 
by Gullstrand). 
 Anterior surface of cornea +7.7 
 Posterior surface of cornea+6.8 
 Anterior surface of lens +10.0 
 Posterior surface of lens–6.0 
 Anterior surface of lens core+7.91 
 Posterior surface of lens core –5.76 
These measurements are known as optical constants of eye. 
Refracting system of reduced eye is expressed in terms of its 
cardinal points (distances in mm behind anterior surface of cornea)  
 Principal point P 1.35 
 Nodal point N 7.08 
 First focal point –15.7 
 Second focal point 24.13 
The corresponding focal lengths, measured from the principal point 
are –17.05 mm and 22.78 mm. Note that the nodal point lies in the 
posterior part of the lens, while the second focal point lies 24.13 mm 
behind the cornea, i.e. on the retina of the normal eye. 
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Figure 1 Reduced eye(Gullstrand) 
In an emmetropic eye, the second principal focus falls on the 
retina. Hence Parallel incident light is therefore focused on the retina, 
without accommodative effort. 
 
Figure 2 Emmetropia 
The emmetropic state is compatible with a range of refractive 
powers, if the axial length of the eye is appropriate to its dioptric power. 
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1. The far point of distinct vision is the position of an object such that 
the image of the object falls on the retina in the relaxed eye, i.e. with 
accommodation at rest. The far point of the emmetropic eye is at 
infinity. 
2. The near point of distinct vision is the nearest point at which an 
object can be clearly seen when maximum accommodation is used. 
3. The range of accommodation is the distance between the far point 
and the near point. 
4. The amplitude of accommodation is the difference in dioptric 
power between the eye at rest and the fully accommodated eye. 
5. The dioptric power of the resting eye is called its static refraction. 
6. The dioptric power of the accommodated eye is called its dynamic 
refraction. 
Optics of Ametropia 
In contrast to emmetropia, the ametropic eye fails to bring the 
parallel rays of light to a focus on the retina, i.e. the second principal 
focal point does not fall on the retina. 
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MYOPIA 
In the myopic eye, the second principal focus lies in front of the 
retina. Myopia or short sightedness is a type of refractive error in which 
parallel rays of light coming from infinity are focussed in front of the 
retina when the accomodation is at rest. 
 
Figure 3 Ametropia-Myopia 
Myopia can be classified as 
 CONGENITAL MYOPIA 
 SIMPLE/DEVELOPMENTAL MYOPIA 
 PATHOLOGICAL/DEGENERATIVE/PROGRESSIVE MYOPIA 
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Congenital myopia 
Myopia present since birth. This type of myopia is very rare. 
Degree of myopia may be around -8.00 D to -10.00 D. Retinal 
degenerations may or may not be associated. Seen more commonly in 
children born with Marfans syndrome and homocystinuria. It may be 
associated with congenital convergent squint, cataract, aniridia, 
megalocornea  etc.  
Simple myopia 
Simple myopia is commonly referred to as physiological or school 
myopia. In simple myopia the refractive structures of the eye develop 
within normal limits. And the refractive power of the eye does not 
correlate with the axial length of the eye. Onset is usually around 
childhood and stops by 21-25 years. The degree of non-pathologic 
myopia is usually minimal to moderate (< 6.00 D). They are not 
associated with retinal degenerations. They have good prognosis. 
Pathological myopia 
Pathologic myopia is defined as a high degree of myopia that is 
progressive and generally presents very early in childhood. Pathologic 
myopia is usually defined as spherical equivalent > 6.00 D or axial length 
>26.5mm with progressive retinal degeneration and other vision 
threatening retinal pathology. 
 8 
 
According to aetiology myopia can be classified as 
 AXIAL  MYOPIA 
 REFRACTIVE MYOPIA 
Further subclassified as  
 CURVATURAL MYOPIA 
 INDEX MYOPIA 
AXIAL  MYOPIA 
This type of myopia occurs due to increase in axial length of the 
eye. Mean Axial length of eye at birth is 15-17 mm. Mean adult axial 
length is 22- 25 mm. 
REFRACTIVE MYOPIA 
This type of myopia occurs due to change in the conditions of 
refractive elements of th eye like refractive index and curvature of the 
refracring surfaces. 
1.CURVATURAL MYOPIA 
Due to an increase in curvature of one or more refractive surfaces. 
eg.keratoconus(corneal surface), anterior and posterior lenticonus( lens 
surface)  
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2.INDEX MYOPIA   
Due to variation in refractive index. eg. Diabetic myopia,  incipient 
cataract. 
 
Figure 4 Refractive and Axial Myopia 
Myopia can also be classified based on the degree of myopia as 
 Low myopia (< -3.00 D) 
 Moderate myopia (-3.00 D to -6.00 D) 
 High myopia (> -6.00 D) 
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Other types of myopia  
Nocturnal Myopia 
This kind of myopia occurs under conditions of very dim 
illumination. Nocturnal myopia is mostly due to an increase in 
accommodation associated with the decreased accommodative cues in 
darkness. The accommodative dark focus appears to be relatively stable, 
at least over a period of days. 
Pseudomyopia 
Pseudomyopia is generally encountered in younger patients who 
perfoms excessive close work. Excessive/ sustained  near demands result 
in hypertonicity of the ciliary body such that an emmetropic or slightly 
hyperopic patient clinically appears to be myopic.  
Drug induced myopia 
Pharmaceutical Agents That Can Induce Myopia 
 Cholinergic agonists  
 Acetylcholine 
 Physostigmine 
 Pilocarpine  
 Antihistamines 
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Risk factors for Myopia 
 Family history of myopia. If one parent is myopic, risk is 5 – 37%. 
If both parents are myopic , risk is increased to 11-57% 
 Presence of myopia in infancy decreasing to emmetropia before 
entering into school 
 Decreased accommodative function 
 Substantial amount of near work on a regular basis 
 During infancy conditions which temporarily obscures the retina 
from clear image falling on it. 
 
Some conditions that are associated with myopia 
 Albinism 
 Down syndrome 
 Marfan syndrome 
 Homocystinuria 
 Ehlers Danlos ysndrome 
 Laurence Moon Biedl syndrome 
 Alport syndrome 
 
Clinical features of myopia 
Symptoms includes defective distant vision , headache, floaters. 
Signs include prominent eyeballs, deep anterior chamber and fundus 
changes 
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FUNDUS CHANGES IN MYOPIA  
In myopia vitreous degeneration is more common. The initial 
structural change is liquefaction of vitreous. Pockets of fluid vitreous is 
formed in vitreous gel. Later this fluid will escape causing vitreous 
collapse and therefore vitreous detachment occurs. In higher degrees of 
myopia, onset of vitreous degeneration is much earlier. Chemical  
composition also plays role in degeneration. In myopes the fraction of 
hyaluronic acid is less compared to others.  Earliest sign of vitreous 
degeneration is extended duration of vitreous fibrillary movements 
following saccades. 
In myopes shallow cupping of the disc is seen normally. This is 
due to increase in area of posterior sclera foramen. This cupping is 
usually seen in moderate myopes.  
Crescent formation is seen in moderate to high myopic eyes. Here 
there is pathological stretching of posterior segment of the globe. This 
causes falling short of choroid or retinal pigment epithelium at the disc. 
Hence the sclera is exposed. Any part of the disc can be involved. 
Commonly temporal side is involved.  
Crescent can be of two types. Scleral crescent which is seen in fair 
complexioned people that appears small. And choroidal crescent which 
appears larger and seen in dark complexioned people showing mottled 
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appearance with pigmentation. If supertraction is present it will give an 
impression of temporal tilting. 
Another feature is posterior staphyloma. Staphyloma can occur 
anywhere. Most common location is at posterior pole. Staphyloma can 
involve macula also. 
Foster fuchs spots are circular pigmented lesion due to subretinal 
hemorrhage and neovacularisation at the macula. Tigroid appearance of 
fundus due to visible prominent large choroidal vessels following atrophy 
of RPE & Choriocapillaris 
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Figure 5 Few Fundus changes in myopia A.Choroidal 
neovascularisation B.Macular degegration C.Posterior staphyloma D. 
Geographical atrophy 
Various degenerations occur in the peripheral retina. They can be of  
1. Intra-retinal Degenerations :   
 Microcystoid degenerations (Typical & Reticular) 
 Senile retinoschisis  
 Pars plana cysts 
2. Retino-vitreal degenerations :   
 Lattice degeneration 
 Snail-track degeneration 
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 White with pressure 
 White without pressure 
3. Chorioretinal degenerations :  
 Paving stone degeneration 
 Chorio retinal degeneration. 
Intra-Retinal Degenerations 
1. Microcystoid degeneration 
It is One of the frequent degenerative lesion seen in myopia. They 
are characterized by small bubbles or vacuoles in the peripheral retina 
near ora serrata. These occur in the outer plexiform and inner nuclear 
layers of retina. They are mostly symmetrical. They are more common in 
temporal retina than nasal, more superiorly than inferiorly. It usually does 
not predispose to retinal detachment. 
Another type of degeneration is called Reticular Cystoid 
Degeneration. These are histologically different and more posterior 
compared to regular cystoids degeneration. 
2. Senile Retinoschisis 
This occurs in about 2 – 4% of population. Lesions appears like a 
bullous elevation of peripheral retina. It is more common in infero-
temporal segment. Incidence is higher in cases of hypermetropia. It 
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occurs as a result of extension of microcystoid degeneration, traction by 
zonular fibres and poor peripheral vascularization. There is no changes in 
the vitreous specific to this lesion. They are mostly asymptomatic. It 
remains immobile with movement of eyeball and produces an absolute 
field defect. It may enlarge leading to Retinal detachment if a break is 
present in either or both walls. 
 
Figure 6 Retinoschisis 
3. Pars Plana Cysts 
Clear bullous elevation of non-pigmented ciliary epithelium of pars 
plana. Usually more prominent temporally underneath the vitreous base. 
It is found to contain hyaluronic acid.  
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Retino-Vitreal Degenerations 
1. Lattice Degeneration 
Lattice degeneration of retina is of important, as they can cause of 
rhegmatogenous retinal detachment. It is a sharply demarcated 
circumferentially oriented lesion located anterior to equator characterised 
by retinal thinning with abnormality in the adjacent vitreous.  
They appears localized round, oval or linear shaped retinal 
thinning, with or without pigmentation, whitish-yellow flecks, sometimes 
with small atrophic round holes.  Rarely tractional tear occurs at the ends 
or posterior margins of lesions. Usually one, but sometimes two or more 
of these features predominate in each individual lesion. 
 
Figure 7 Lattice degeneration 
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2. Snail track degeneration 
These are characterized by groups of glistening white dots. They 
are found in the area of the equator or just in front of the equator. 
Histologically, this lesion consists of degeneration of the neural elements 
of retina leading to an atrophy of the tissues with lipid deposits in the 
internal retinal layers. 
 
Figure 8 Snail track degeneration 
3. White With Pressure  
Distinct milky white or opalescent appearance of the peripheral 
retina that is observed with scleral depression. Retina appears normal 
without depression. It is common one and seen in around 30 to 35% of 
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eyes examined with scleral depression. Infero-nasal quadrant least likely 
to be affected. 
4. White Without Pressure 
Distinctive white appearance of the peripheral retina without 
indentation. Whiteness further increased if sclera indentation is done. 
Margins are sharply demarcated from normal retina. Can predispose to 
retinal detachment. 
 
Figure 9 White without pressure 
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Chorioretinal Degenerations 
1. Paving Stone Degeneration 
Lesion appears as yellow-white multiple rounded punched-out 
areas of choroidal and retinal atrophy. These lesions have discrete 
margins which may be pigmented. And they are located between ora 
serrata and equator with size of one to several disc diameters. They are 
more common in infero-nasal quadrant.  
 
Figure 10 Pavingstone degeneration 
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Correction of high myopia 
Optical correction – Spectacles (concave lens) or Contact lens (soft 
contact lens) can be used for correction of high myopia. There are certain 
basic rules as given below 
Low degrees(<-6.00 D): 
 Young patients needs full correction. Should be on constant use 
to have normal  accommodation convergence reflex 
 Adult wearing for the first time needs slight under correction 
with comfortable near vision. 
 Adults >40 years needs full distance and near correction. 
 Should not over correct these people  
High degrees(>-10.00 D) 
 Full correction is rarely tolerated 
 Undercorrect 1-3D to avoid difficult near vision and 
minification 
 Compound telescopic spectacles can be use 
Advantages of spectacles for patients with myopia are: 
1. economical. 
2. Spectacles readily allow the incorporation of other optical 
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treatments (e.g., prism, bifocals) 
3. Spectacles require less accommodation than contact lenses for 
myopia 
Problems with spectacles 
1. Prismatic aberrations 
2. Field of vision will be less 
3. Tend to fog up 
4. Cosmetically low in acceptance 
Contact lens 
Contact lens can be of soft contact lens, or soft toric lens, or 
spherical RGP. It can be of toric RGP if astigmatism is more than -2.00D. 
It can be of daily wears, or extended wears, monthly wears. 
Contraindications for contact lens 
 Poor motivation 
 Styes, blepharitis, chronic dacrocystitis, conjunctivitis, corneal 
dystrophies and degeneration, episcleritis, scleritis  
 7th nerve palsy 
 Poor personal hygiene 
 Dry eyes/allergic patients 
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Some advantages of contact lenses for patients with myopia are: 
1. Provide better cosmesis. 
2. Provide a larger retinal image size 
3. Better visual acuity. 
4. Contact lenses result in less aniseikonia in anisometropia. 
5. Reduced visual field Restrictions 
6. Avoids prismatic aberrations and peripheral distortion 
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REFRACTIVE PROCEDURES  
Refractive surgeries can also be done for myopia. Refractive 
surgeries have become widely popular in these days.  
(A) CORNEA BASED PROCEDURES- It can be of 
1. Incisional procedures- RK 
2. Lamellar corneal refractive procedures- Epikeratophakia, ReLex 
3. Laser abalation corneal refractive procedures- PRK, LASIK, C-
LASIK,LASEK, EPI-LASIK 
4. Orthokeratology 
5. Intracorneal implants- INTACS 
(B) LENS BASED PROCEDURES 
1. Phakic refractive lenses 
2. Refractive lens exchange 
(C) COMBINED LENS AND CORNEA BASED REFRACTIVE 
PROCEDURES 
1. Bioptics 
2. Trioptics  
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ReLex 
ReLex or Refractive Lenticule Extraction is a refractive lamellar 
corneal surgery that modifies corneal stroma (by removal of a stromal 
lenticule) so that radius of curvature of anterior corneal surface is altered 
as desired. Uses FEMTOSECOND laser and so called All femtolaser 
vision correction. It is of two ways   
1. FLEX(Femtosecond Lenticule EXtraction): It includes extraction 
of stromal lenticule after making a full corneal flap 
2. SMILE(Small Incision Lenticule Extraction): It includes extraction 
of lenticule through a small cut in anterior flap (only 40-60 degree 
flap made) 
INTRASTROMAL LASER ABLATION PROCEDURES  
 Laser in-situ keratomileusis(LASIK)10 
 Custom laser in-situ keratomileusis(C –LASIK)  
ADVANCED SURFACE ABLATION PROCEDURES  
Surface ablation procedures are associated with better technique of 
epithelium removal, larger ablation zone, use of Mitomycin- C to 
decrease the proliferative haze. It includes  
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 Advanced Photorefractive keratectomy – involves Mechanical 
debridement of epithelium with beaver knife/spatula/epithelial 
scrubber 
 Laser subepithelial keratomileusis(LASEK)- involves Alcohol 
debridement of epithelium(20 % alcohol) 
  Epithelial Laser Insitu Keratomileusis(EPI-LASIK) – using Epi-
microkeratome. 
ORTHOKERATOLOGY 
Non surgical reversible method of moulding the cornea with 
overnight wear of unique rigid gas permeable contact lenses to correct 
myopia. Useful at any age with spherical prescription  < -4.00 D & 
astigmatism <-1.50 D 
LENTICULAR REFRACTIVE PROCEDURES : It Includes  
1. Refractive Lens Exchange(RLE) : It is done for  -16.00 D to -30.00 
D. It includes clear lens extraction by phacoemulsification with 
IOL implantation. Can use monofocal IOLs, multifocal IOLs, 
pseudo-accomodative and accommodative IOLs 
2. Phakic Refractive Lenses(Phakic IOLs): It involves placing an 
artificial lens in the eye without touching the normal crystalline 
lens so accommodation not disturbed. 
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COMBINED PROCEDURES-  
For very high refractive errors where a single procedure may not 
suffice, combination of different techniques may be used. It can be of 
1. BIOPTICS 
It involves two refractive procedures. eg; RLE with LASIK, Phakic 
IOL with LASIK8. 
2. TRIOPTICS 
It involves combination of three procedures. eg; Toric IOL in the 
bag + multifocal IOL in sulcus +LASIK.  
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PHAKIC IOL 
Phakic IOL means that natural crystalline lens is retained and an 
intraocular lens (IOL) is placed into the eye. Phakic IOLs are used to treat 
high myopia or hyperopia with or without astigmatism who are not fit for 
LASIK or mild keratoconus5. 
Phakic intra ocular lens has become widely popular in recent times. 
They give optimum results with minimal complications. It was introduced 
by strampelli. Then modified by fydrovov.  Initially anterior chamber 
phakic IOLs were introduced, later iris fixated lens were developed.  
But recently posterior chamber phakic intra-ocular lens were of 
used greatly because of greater efficacy and safety with maximum 
satisfaction2. 
Types of Phakic IOL 
According to the site of implantation phakic IOL can be classified as 
1. Anterior chamber phakic IOL 
2. Iris fixated Phakic IOL 
3. Posterior chamber IOL 
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Anterior chamber Phakic IOL: 
Known by the name NOVITA MA 20. These lens were prone to 
several complications like  loss of corneal endothelium leading to bullous 
keratopathy, compromising the anterior chamber leading to angle closure 
glaucoma and intraocular inflammation12. Hence these kind of lens were 
not popular and they went out of practice.   
 
Figure 11 Anterior Chamber Phakic IOL 
Iris fixated  phakic IOL 
Examples of these lens are Artisan lens. These lens had problems 
like pigment dispersion , iristis which leads to glaucoma and progressive 
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loss of corneal endothelium. Hence these lens also were not quite 
popularized. 
 
Figure 12 Iris Fixated Phakic IOL 
Posterior chamber phakic IOL 
These lens are commonly used now a days. They are more 
efficacious, safe with better outcomes. Phakic IOL implantation induces 
significantly fewer ocular Higher Order Aberrations than LASIK. 
Moreover, Contrast sensitivity was significantly improved after phakic 
IOL implantation but unchanged after LASIK in eyes with low to 
moderate myopia. Thus, even in the correction of low to moderate 
myopia, phakic IOL appears to be superior in visual performance to 
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LASIK1 ICL(Implantable Collamer  Lens), RIL (Refractive Implantable 
Lens), EyePCL are prototype to this generation.  
 
 
Figure 13   ICL 
ICL 
Introduced by STAAR surgcical co, USA. Made up collamer, the 
combination of collagen and HEMA polymer. Posterior surface of the 
lens is concave and therefore it provides a space between anterior surface 
of the crystalline lens and posterior surface of the phakic IOL which is 
called vault. 
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RIL 
Introduced by one of the Indian company. Made up of hydrophilic 
acrylic material. Four Peripheral Holes for aqueous humor flow. These 
lens have  a leading hole on right and a trailing hole on left. Found to be 
safe and effective, 
 
MATERIAL HEMA – HYDROPHILIC 
OPTIC SIZE 4.50 mm to 5.80mm 
OVERALL 11.50 mm to 13.25 mm 
REFRACTIVE INDEX 1.460 
DIOPTER -1.0D TO -23.0D  
STERILIZATION STEAM 
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Figure 14 RIL 
Indications  
 Age group of 18-40 yrs with stable refraction 
 Correct myopia of range -6.00 D to -21.00 D 
 Endothelial count should be > 2500 cells/mm2  
 Anterior chamber depth should be >2.7 mm 
 Angle of the anterior chamber should be more than grade II 
by Gonioscopy 
 Absence of any lens changes 
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Contraindications 
 Progressive Change in refractive error which is not stable 
 Shallow anterior chamber with less than grade II by 
gonioscopy 
 Anterior chamber depth  with < 2.7 mm 
 Endothelial count <2500 cells/mm2 
 Any lens changes 
 Any retinal degeneration which causes impaired vision 
 Any inflammatory pathologies of eye 
Pre –operative Evaluation 
 Visual acuity using Snellen’s acuity chart 
 Slit lamp biomicroscopy of anterior segment 
 Intraocular pressure using Goldmann Applanation tonometer 
 Gonioscopy  
 Direct and Indirect ophthalmoscopy  
 A Scan , Keratometry Reading  
 B Scan Ultrasonography 
 Endothelial count by Specular microscopy 
 Central Corneal Thickness(CCT) by Pachymetry  
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 Orb Scan-To look for HVID(horizontal vertical iris 
diameter), CCT, Anterior chamber depth, Iridocorneal angle 
 White to white measurement by Digital calipers 
 
Figure 15 Corneal topography (orbscan/sirius scan) 
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Procedure 
Posterior chamber IOL is placed in the posterior chamber behind 
the iris and rests against the bag of crystalline lens. It is made of collamer, 
the combination of collagen and HEMA polymer.  
Under local anaesthesia, a small incision of size 2.8 mm- 3.2mm is 
made in the cornea at 12 o’ clock position. Two side port incisions made 
at 10 & 2 o’clock positions. 
 
Figure 16 RIL loading into cartridge 
Loading of lens into the cartridge is very important. Place the lens 
and ensure it has been seated in the groove of the wings. Then the wings 
are folded making sure lens is not trapped and should slide smoothly.  
Cartridge with loaded lens is inserted with bevel down through the 
incision made at 12 o’clock position. The tip of the injector is kept 
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superficially and the phakic IOL is injected gently into the AC, taking 
care not to damage the anterior capsule of lens or the iris. Then IOL is 
gently positioned horizontally with blunt tip manipulator.  
 
Figure 17 Intra op pic showing leaading hole of RIL 
Then intracameral pilocarpine (miotic) is used so that pupil gets 
constricted and facilitates peripheral iridectomy superiorly. 
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Figure 18 Intra OP -  Peripheral Iridectomy 
 
Figure 19 Post op picture showing phakic IOL 
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Post operative evaluation 
 Uncorrected visual acuity, best corrected visual acuity 
 Intra ocular pressure 
 Anterior chamber depth 
 Endothelial count 
 
Figure 20 SLE showing Pkakic IOL  and crystalline lens 
 
 Anterior segment OCT- to look for vault.  
Vault should be 300-740 microns. If it is <300 microns it can cause 
lens changes. If it is >750 microns it can cause pigment dispersion and 
closed angle glaucoma 
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Figure 21 AS OCT showing Vault 
Advantages 
 Safer4 
 Can be done for thin cornea where LASIK is contraindicated 
 Reversible unlike LASIK 
 Preserves accommodation 
 No flap related complications unlike LASIK 
 No corneal tissue is removed thus corneal asphericity is 
retained. 
 Tear film abnormality is absent 
Vault of 724 
micron 
Anterior surface of 
crystalline lens 
Posterior surface 
of  phakic IOL 
Anterior surface of phakic IOL 
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Figure 22 Before and after surgery 
Complications 
 Uveitis  
 Glaucoma 
 Early cataract formation3  
 Improper vault due to faulty loading of lens in the cartridge 
 Very rarely Retinal detachment can occur. 
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AIM AND OBJECTIVE 
To evaluate the efficacy and visual outcome of posterior chamber 
phakic IOL in high myopic patients. 
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MATERIALS & METHODS 
This prospective study was conducted at Cornea and Contact Lens 
department, RIOGOH, Egmore, Chennai from Feb - August 2017.  
Methodology: 
Patient presented to Cornea and Contact Lens services were 
registered, evaluated and followed up during the study period.  
A detailed history of the patient, Best corrected visual 
acuity(BCVA), Slit lamp examination, and fundus examination, 
Gonioscopy, endothelial count by specular microscopy, CCT by 
pachymetry, A scan & B scan USG, AS-OCT  were done. Endothelial 
count, anterior chamber depth, central corneal thickness were measured 
during presentation and follow up period. Distance between anterior 
surface of phakic IOL and endothelium were measured during follow-up 
period 
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INCLUSION CRITERIA: 
1. Age  >18 years 
2. Stable refraction 
3. Patients with myopia > -6.00D 
4. Iridocorneal angle > 30 degree 
5. Anterior chamber depth >2.7mm 
6. Endothelial cell count > 2500 cells/sq.mm 
7. Central corneal thickness >0.400 mm  
EXCLUSION CRITERIA:  
1. Age  <18  years 
2. Unstable refraction 
3. Hyperopia  
4. Astigmatism. 
5. AC depth <2.7 mm. 
6. Iridocorneal angle <30 degrees   
7. Endothelial cell count<2500 cells /sq mm 
8. Central corneal thickness <0.400 mm 
9. Any lens changes 
10. Any retinal degeneration which causes impaired vision 
11. Any inflammatory pathologies of eye 
12. Any previous ocular surgeries   
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SCREENING PROCEDURES/ VISITS: 
 Detailed history of present illness 
 Visual acuity using Snellen’s acuity chart 
 Slit lamp biomicroscopy of anterior segment 
 Intraocular pressure using Goldmann Applanation tonometer 
 Gonioscopy 
 Direct and Indirect ophthalmoscopy  
 White to white measurement by digital caliper  
 A Scan , K Reading , IOL Power 
 B Scan USG 
 Endothelial count by Specular microscopy 
 CCT by Pachymetry  
 Orb Scan-HVID, CCT, AC depth, Iridocorneal angle 
Follow up Procedures / Visits: 
 Uncorrected visual acuity 
 Best corrected visual acuity 
 IOP  
 Endothelial count  
 CCT   
 Orb Scan- HVID, CCT, AC depth, Iridocorneal angle 
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 AS-OCT – vault (distance between phakic IOL and corneal 
endothelium in the post-op period) 
Follow up visits on 1st ,  3rd week,  3rd  month 
ASSESSMENTS OF PARAMETERS : 
 Improvement in Best corrected visual acuity by Snellen’s chart 
 Intra ocular pressure by applanation tonometry 
 Anterior chamber depth by orb scan 
 Iridocorneal angle by gonioscopy 
 Endothelial count by specular microscopy 
 Central corneal thickness by pachymetry 
 Distance between anterior surface of phakic IOL and corneal 
endothelium by AS-OCT. 
  
 47 
OBSERVATION AND ANALYSIS 
The purpose of the study is to find out the efficacy and safety of 
Posterior chamber Phakic intraocular lens. The study has been conducted 
on 50 eyes of 34 patients, of which 53% are male and the 47% are 
female. The average age of a patient is 25.24 years with the standard 
deviation of 5.15 years. In addition, the results showed that 59% of 
patients treated for Right Eye (OD), while 41% of patients treated for 
Left Eye (OS).  
Percentage of Patients treated for Left Eye (OS) or Right Eye (OD) 
with phakic IOL 
Eye Number of eyes % Percentage 
OD 20 59% 
OS 14 41% 
Total 34 100% 
 
  
59%
41%
LATERALITY
OD OS
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Gender Distribution 
SEX Number of eyes % PATIENTS 
Male 18 53% 
Female 16 47% 
Total 34 100% 
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Parameters Measured 
The parameters measured in this study are listed below:   
S. No. Parameters or Variables evaluated 
1 VISUAL ACUITY (UCVA & BCVA)  
2 ANTERIOR CHAMBER DEPTH   
HVID – HORIZONTAL VERTICAL IRIS DIAMETER 
3 INTRAOCULAR PRESSURE 
4 ANGLE OF ANTERIOR CHAMBER  
5 ENDOTHELIAL COUNT   
6 CENTRAL CORNEAL THICKNESS  
7 VAULTING OF LENS 
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PRE OPERATIVE UNCORRETCED VISUAL ACUITY 
PRE OP UNCORRECTED VISUAL ACUITY 
UNCORRECTED VISUAL 
ACUITY 
NUMBER OF 
EYES 
% OF 
PATIENTS 
1/60 6 12% 
2/60 7 14% 
3/60 13 26% 
4/60 10 20% 
5/60 10 20% 
6/60 4 8% 
>6/60 0 0% 
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PRE OP BEST CORRECTED VISUAL ACUITY 
PRE OP BCVA NUMBER OF EYES %PERCENTAGE OF EYE 
6/6 9 18% 
6/9 10 20% 
6/12 8 16% 
6/18 15 30% 
6/24 4 8% 
6/36 4 8% 
6/60 0 0% 
<6/60 0 0% 
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POST OP 1st WEEK- UNCORRECTED DISTANCE VISUAL 
ACUITY 
Post Op Ist Week Un Corrected Visual Acuity 
UNCORRECTED 
VISUAL ACUITY 
NUMBER OF 
EYES % OF PATIENTS 
6/6 16 32% 
6/9 19 38% 
6/12 6 12% 
6/18 5 10% 
6/24 3 6% 
6/36 1 2% 
6/60 0 0% 
<6/60 0 0% 
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POST OP 3rd MONTH - UNCORRECTED DISTANCE VISUAL 
ACUITY 
Post Op 3rd  MONTH Uncorrected Visual Acuity 
UNCORRECTED VISUAL 
ACUITY 
NUMBER OF 
EYES 
% OF 
PATIENTS 
6/6 27 54% 
6/9 16 32% 
6/12 5 19% 
6/18 0 0% 
6/24 2 4% 
6/36 0 0% 
6/60 0 0% 
>6/60 0 0% 
 
 
0%
10%
20%
30%
40%
50%
60%
6/6 6/9 6/12 6/18 6/24 6/36 6/60 <6/60
POST OP 3rd MONTH UCVA
PERCENTAGE OF PATIENTS
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To test whether post-operative UCVA is better than pre-operative 
BCVA 
The result showed that 100% of the eyes were found to have 
improvement in Uncorrected Visual Acuity (UCVA) following surgery. 
And also showed improvement in Best Corrected Visual Acuity (BCVA) 
after surgery.  
In Particular, the analysis of Visual Acuity showed that 92% of the 
eyes (x = 46 eyes) had better post–operative UCVA than pre-operative 
BCVA, while 8% (x = 4 eyes) showed that post-op BCVA was same as 
pre-op BCVA. The single proportion test has been applied to test the 
following hypotheses:  
Null hypothesis, H0: Majority of the eyes don’t get significant 
improvement from Pre-Operative BCVA to Post-Operative UCVA 
Alternate hypothesis, Ha: Majority of the eyes got improvement 
from Pre-Operative BCVA to Post-Operative UCVA 
Test applied: Single Proportion Test  
Result: Z = 5.94 and p-value = 0.000 < 0.05 
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Conclusion: Since the p-value of the test statistic is less than 0.05, 
we reject the null hypothesis at 5% level. Hence, the evidence is 
sufficient to conclude that the majority of the eyes had better post-op 
BCVA than pre-op UCVA.  
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PRE OPERATIVE MANIFEST SPHERICAL EQUIVALENT 
PRE OPERATIVE MANIFEST SPHERICAL EQUIVALENT 
SPHERE NUMBER OF EYES % OF PATIENTS 
- 6.00D  to -10.00D 7 14% 
-10.25D to -15.00D 26 52% 
-15.25D to -20.00D 17 34% 
>-20.00D 0 0% 
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POST OP 3rd MONTH MANIFEST SPHERICAL EQUIVALENT 
3rd MONTH POST OPERATIVE SPHERICAL EQUIVALENT 
SPHERICAL POWER NUMBER OF EYES % OF PATIENTS 
-1.00 D 1 2% 
-0.75 D 1 2% 
-0.5 D 7 14% 
0.00 D 41 82% 
+0.5 D 0 0% 
+0.75 D 0 0% 
+1.00 D 0 0% 
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PRE OPERATIVE ANTERIOR CHAMBER DEPTH 
PRE OPERATIVE ANTERIOR CHAMBER DEPTH 
ACD NUMBER OF EYES % OF PATIENTS 
< 2.5mm 0 0% 
2.5mm -  3.2mm 44 88% 
> 3.2mm 6 12% 
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2.5mm- 3.2mm
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0%
88%
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POST OP ANTERIOR CHAMBER DEPTH 
 
To test whether there is significant reduction in anterior chamber 
depth after surgery 
Null hypothesis, H0: There is no significant reduction in AC Depth after 
surgery 
Alternate hypothesis, Ha: There is significant reduction in AC Depth 
after surgery 
Test applied: Paired Sample t-test  
0%
94%
6%
<2.2 mm
2.2-2.8 mm
>2.8mm
POST OP AC DEPTH
POST OP AC DEPTH
 60 
 
Result: t = -16.78 and p-value = 0.000 < 0.05 
 
Conclusion: 
Since the p-value of the test statistic is less than 0.05, we reject the 
null hypothesis at 5% level of significance (t = -16.78, p < 0.05). Hence, 
the evidence is sufficient to conclude that there is significant reduction in 
AC Depth from Pre to Post Operation. Going by the mean values, we see 
that the mean AC Depth before surgery is 3.06 (SD = 0.22) and that of 
after surgery is 2.47 (SD = 0.18).  
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PRE OPERATIVE WHITE TO WHITE 
PRE OPERATIVE WHITE TO WHITE 
WHITE TO WHITE NUMBER OF EYES % OF PATIENTS 
< 11.25mm 15 30% 
11.25mm  to  12.25mm 35 70% 
> 12.25mm 0 0% 
 
 
  
< 11.25mm 11.25mm  to  12.25mm > 12.25mm
30%
70%
0%
HVID- WHITE TO WHITE
PERCENTAGE OF EYES
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PRE OPERATIVE INTRAOCULAR PRESSURE 
PRE OPERATIVE INTRAOCULAR PRESSURE 
IOP NO OF PATIENTS % OF PATIENTS 
< 10mmHg 32 64% 
10 -15 mmHg 18 36% 
16 - 20 mmHg 0 0% 
20- 24 mmHg 0 0% 
>24 mm Hg 0 0% 
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POST OP 1st WEEK   INTRAOCULAR PRESSURE 
POST OP 1st WEEK   INTRAOCULAR PRESSURE 
IOP NUMBER OF EYES % OF PATIENTS 
< 10 mmHg 0 0% 
10mmHg -  15mmHg 24 48% 
16mmHg - 20mmHg 25 50% 
21mmHg- 24 mm Hg 1 2% 
>24 mm Hg 0 0% 
 
 
  
POST OP 1ST WEEK IOP
< 10 mmHg 10mmHg - 15mmHg 16mmHg - 20mmHg
21mmHg- 24 mm Hg >24 mm Hg
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POST OP 3rd MONTH   INTRAOCULAR PRESSURE 
POST OP 3rd Month INTRAOCULAR PRESSURE 
IOP NUMBER OF EYES % OF PATIENTS 
< 10 mmHg 0 0% 
10 -  15mmHg 16 32% 
16- 20mmHg 34 64% 
21-24 mmHg 0 0% 
>24 mm Hg 0 0% 
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To test whether there is significant change in IOP following surgery 
The value of IOP is considered to be normal if it is 20 or less. Our 
data shows that 100% of the eyes before surgery (Pre Op) had the IOP 
value of  < 20 mm Hg, while only 98% of the eyes after surgery  had the 
IOP value of < 20 mm Hg . That is, only one eye had an elevated IOP of 
22 mm Hg following surgery which got normalized during follow up.  
Let p be the proportion of eyes at both pre and post operation have 
an IOP value of 20 or less 
Null hypothesis, H0: Majority of the eyes at both pre and post operation 
does not have an IOP value of 20 or less 
Alternate hypothesis, Ha: Majority of the eyes at both pre and post 
operation have an IOP value of 20 or less 
Test applied: Single Proportion Test 
Result: Z = 6.79 and p-value = 0.000 < 0.05 
Conclusion: Since the p-value of the test statistic is less than 0.05, we 
reject the null hypothesis at 5% level of significance (Z = 6.79, p < 0.05). 
Hence, the evidence is sufficient to conclude that majority of the eyes 
before and after surgery have an IOP value of 20 or less. Obviously, this 
result is also supported very strongly by data that 98% of the eyes before 
and after surgery had IOP value of 20 or less.  
 66 
In addition, the mean IOP value at both Pre and Post Operation is 
presented in the following bar chart: 
 
 
The above bar chart clearly shows that the elevation in mean IOP 
from pre-op to post-op is not so high (i.e., 15.18 - 14.38 = 0.80 < 1) and 
mean IOP before and after surgery are less than 20 mm Hg, which 
indicates that the value of IOP and its elevation is at reasonable level 
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To test whether there is significant reduction in Angle of anterior 
chamber following surgery 
Null hypothesis, H0: There is no significant reduction in AC Angle after 
surgery 
Alternate hypothesis, Ha: There is significant reduction in AC Angle 
after surgery 
Test applied: Paired Sample t-test 
 
Result: t = -27.08 and p-value = 0.000 < 0.05 
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Conclusion: Since the p-value of the test statistic is less than 0.05, we 
reject the null hypothesis at 5% level of significance (t = -27.08, p < 
0.05). Hence, the evidence is sufficient to conclude that there is 
significant reduction in AC Angle from Pre to Post Operation. Going by 
the mean values, we see that the mean AC Angle before surgery is 43.04 
(SD = 3.55) and that of after surgery is 31.78 (SD = 2.84). Though the 
mean AC Angle is reduced after the operation, it is greater than 25, which 
indicates that the angles are open.  
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To test whether the reduction in endothelial count after surgery 
The average reduction in “Endothelial Cell Count” after surgery is 
expected to be 120 cells/sq.mm. The number of eyes with the reduction of 
100 or less in “Endothelial Cell Count” was found to be 48 and only 2 
eyes had this reduction as more than 100 but it was less than 125 . This 
result is presented in the following table:  
Reduction in Endothelial Cell Count No. of Eyes % of Eyes 
< 100 48 96% 
> 100 - < 125 2 4% 
Total 50 100% 
 
Null hypothesis, H0: Majority of eyes doesn’t get a reduction of 100 or 
less in Endothelial Cell Counts 
Alternate hypothesis, Ha: Majority of eyes got a reduction of 100 or less 
in Endothelial Cell Counts 
Test applied: Single Proportion Test 
Result: Z = 6.51 & p-value = 0.000 < 0.05 
Conclusion: Since the p-value of the test statistic is less than 0.05, we 
reject the null hypothesis at 5% level of significance (Z = 6.51, p < 0.05). 
Hence, the evidence is sufficient to conclude that majority of eyes got a 
reduction of 100 or less in Endothelial Cell Counts. This result is also 
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supported very strongly by the above table that 96% of the eyes got a 
reduction of 100 or less in Endothelial Cell Counts.  
In addition, the mean Endothelial Cell Counts at both Pre and Post 
Operation is presented in the following bar chart.  
 
The above bar chart clearly shows that he mean reduction from pre 
to post operation is not so high (i.e., 2982.66 – 2891.28 = 91.38 < 100), 
which indicates that this reduction is at expected reasonable level.  
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To test whether there is significant change in Central corneal 
thickness after surgery 
In general, the value of CCT is expected to be in the range of 515 
to 535.  In our case, the number of eyes having the CCT values in this 
range at pre and post operation are shown in the following table: 
CCT in microns  PRE OP POST OP 
 515 - 535 28 (56%) 28 (56%) 
<515 OR > 535 22 (44%) 22 (44%) 
Total 50 50 
 
The above table clearly shows that the percentage of eyes with 
CCT in the range of 515-535 at before and after surgery is equal          
(i.e., 56%). This result suggests that there is no significant change in CCT 
from Pre to Post Operation.  
In addition to the above findings, the bar chart of the mean CCT 
has been constructed and is shown below:  
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The above bar chart clearly shows that the mean CCT values 
before and after surgery are within the normal range of 515-535 and 
difference is also not so high (i.e., 528.42 – 523.74 = 4.68). This findings 
also support our result that the value of CCT doesn’t change from Pre to 
Post Operation.  
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Average Vaulting 
The descriptive statistics has been calculated for Vaulting and the 
corresponding result showed that the average vaulting is 508.28 microns 
with the standard deviation of 114.95. The minimum and maximum 
values of vaulting are 320 microns and 726 microns respectively. The 
values of this vaulting is in the acceptable range of 300 to 750 microns. 
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DISCUSSION 
 In our study we have evaluated 50 eyes of 34 patients. Mean age 
group was 25.24 ± 5.15 yrs. These patients were followed up for a 
mean period of 6 ±3 months.  
 Mean post op spherical equivalent power was -0.50 D ±1.00 D. 
post op BCVA of 92 % eyes was better than pre op UCVA and 8% 
had same as post op BCVA.  
 There was no incidence of cataract in our study. 
 Only one eye (2%) had increased IOP during the post operative 
period. 
 There was no significant change in endothelial count among these 
patients. Around 3.5% reduction in endothelial cells was observed 
in our study.  
 In our study, mean pre- op AC depth was 3.06 mm and post- op 
AC depth was 2.57 mm. There was significant reduction in AC 
depth in all patients, but it was not < 2.4 mm. 
 Pupillary block, Pigment dispersion , iritis and retinal detachment 
were not observed in our study that were observed in other studies 
as shown in table below. 
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Author and 
reference Yan Ju et al 
Uusitalo RJ 
et al 
Perzcamtro
di et al Lee J et al 
Year 2013 2002 2011 2016 
Patients 82 eyes of  43 pts 
38 eyes of 22 
pts 
35 eyes of  
20pts 
281 eyes of 
145 pts 
Mean follow 
up 3-12 months 36months 58 months  
Mean post op 
SE -1.85±0.7 D 
-2.00D±-
2.48D 
-1.00 D± 
0.50D 
-
0.58±0.72D 
Post op 
UCVA 
96% had equal 
or better than 
pre op BCVA 
71.9% had 
equal or 
better than 
pre-op BCVA 
85.71 %had 
equal or 
better than 
- 
IOP change 8%  eyes IOP increase -  
2eyes had 
elevated 
IOP 
Lens 
transparent No change 
2.6 % pts  
cataract 
Reduced by 
12.86% 
2.1% 
cataract 
Endothelial 
loss Not significant -- 
 
- 
8%endotheli
al cell loss 
AC depth 
Significant 
reduction 
3.58±0.14mm 
to 
2.45±0.22mm 
 
-- - - 
Specific 
complications 
Pigment 
dispersion 6% 
7.9% 
pupillary 
block 
- - 
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RESULTS 
This report includes data of 50 eyes of 34 patients in the age group 
of 19 - 39 years implanted with posterior chamber phakic IOL as per the 
inclusion criteria. Pre-operatively patient’s data like uncorrected Visual 
acuity, best corrected visual acuity, subjective and retinoscopic refraction, 
Indirect ophthalmoscopic examination, Anterior Chamber Depth, and 
Central Corneal Thickness, Endothelial cell count, Keratometry readings, 
Axial Length, White to White, Intraocular pressure were collected. Post- 
operatively patient’s uncorrected Visual acuity, best corrected visual 
acuity, Manifest Refraction , Endothelial cell count, central corneal 
thickness, Intraocular pressure, Vaulting of lens using AS-OCT. 
Peripheral Iridectomy was done for all the patients for better aqueous 
flow. Patients were followed on Post operative Day 1, Day 3, 3rd week, 
3rd month. 
 Pre operatively 30% eyes had BCVA of 6/18, 20% eyes had 6/9, 
16% eyes had 6/12, 18% had 6/6. 8% eyes had 6/24 and 6/36 each. 
 post –operatively 32% had UCVA of  6/6, 38% eyes had 6/9. 12% 
eyes had 6/12, 10% eyes had 6/18. And 6% eyes had 6/24. 
 In 1st week post operative UCVA was less than pre-operative 
BCVA in 6% of eyes whereas 94% of eyes had equal or better 
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UCVA than pre-operative BCVA.  At the end of 3rd month all eyes 
(100%) showed equal or better UCVA than pre-operative BCVA.  
 Pre operative spherical equivalent power for 14% of eyes were 
between -6.00D and -10.00D, 52% of eyes were between -10.25D 
and -15.00D. Remaining 34% of eyes were between -15.25D and 
20.00D 
 In 3rd month Post OP visit there was a Spherical error of -0.50D in 
14% of eyes and –0.50D to -0.75D Spherical error in 4% of eyes. 
There was no Spherical error in 82% of eyes. 
 Pre –operatively 88% of eyes had AC Depth between 2.5mm and 
3.2mm, remaining 12% of eyes had above 3.2mm. 
 Post –operatively 94% of eyes had AC depth between 2.2-2.8mm, 
remaining 6% of eyes had above 2.8 mm 
 Pre –operatively 30% of eyes had HVID-horizontal vertical iris 
diameter (white to white) of less than 11.25mm and 70% of eyes 
had between 11.25mm and 12.25mm. None of the eyes had above 
12.25mm 
 Pre-operatively 64% of eyes had IOP of 10-15mmHg. 32% of eyes 
had IOP between 16 and 20mm hg.  
 In 1st week Post OP, 48% of eyes had IOP between 10- 15mmHg, 
50% of eyes had between 16-20 mm Hg. So 98% of eyes had IOP 
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less than 20 mm Hg. Only One eye (2%) showed IOP of >20 mm 
Hg.  In 3rd week Post OP and 3rd month Post Op, all eyes had IOP 
<20 mmHg.  
 There wasn’t much change in central corneal thickness post 
operatively and Pre operatively. 
 Post operatively 96% of eyes had reduction in endothelial cell 
count of <100 cells /mm2 which was not significant.  
 In 1st week Post Op, 3rd week and in 3rd Month all the patients had 
vaulting of 300 -750 microns. 
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CONCLUSION 
According to the results of our study , there is sufficient evidence 
to conclude that the posterior chamber phakic intraocular lens are safe 
and effective in patients with high myopia in terms of parameters like AC 
depth, Angle of Anterior chamber, Endothelial Cell Count, IOP, Central 
Corneal Thickness and Vaulting of phakic IOL that were measured in this 
study. And these lenses were found to have better visual outcome without 
altering the anatomy of cornea.  Dry eye symptoms which are common in 
patients undergoing ablative procedures like LASIK, Epi-LASIK are 
absent in these patients. These phakic IOLs can be implanted for patients 
who have corneal ectasia like keratoconus or thin cornea where ablative 
procedures are contraindicated. And moreover patients with mild 
astigmatism can also be benefited with this type of lens. For all these 
patients long term follow up is needed.  
Hence posterior chamber phakic IOLs can be used for patients with 
high myopia. 
  
PROFORMA: 
 Name  : 
 Age/sex : 
 I.P no : 
 Chief complaints: 
 Treatment history : 
Medications 
Surgery 
 Personal history : 
 Family history 
 
 Genral examination 
 Systemic examination 
 
 Local examination 
RE                                          LE 
Visual acuity 
Uncorrected visual acuity (ucva) 
  
Best corrected visual acuity(bcva) 
Extra ocular movements 
Iop  
Lids : 
Conjunctiva : 
Cornea :. 
Iris : 
Anterior chamber : 
Pupil : 
Lens : 
 Retinoscopy 
 Fundus : 
 Gonioscopy 
 A scan  
 Keratometry   
 B scan USG 
 Endothelial count by specular microscopy 
 CCT by pachymetry 
 Anterior chamber depth by as-oct 
  
 Orbscan 
o HVID 
o Ac depth 
o Angles 
o CCT 
 White to white by digital calipers 
 
 Post op on day 1, one week, 4 week, 3 month 
UCVA 
BCVA 
IOP 
GONIOSCOPY 
CCT 
Endothelial count 
AC depth 
Vault by AS OCT 
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KEY TO MASTER CHART 
 
1. UCVA - Uncorrected Visual Acuity 
2. BCVA - Best Corrected Visual Acuity 
3. SE  - Spherical Equivalent 
4. IOP  - Intraocular Pressure 
5. ACD  - Anterior Chamber Depth 
6. CCT  - Central Corneal Thickness 
7. HVID - Horizontal Vertical Iris Diameter 
8. AS-OCT - Anterior Segment Optical Coherence  
Tomography 
 
 
